Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening

Sahin, 2014, mRNA-based therapeutics--developing a new class of drugs, Nat. Rev. Drug Discov., 13, 759, 10.1038/nrd4278 Pardi, 2018, mRNA vaccines - a new era in vaccinology, Nat. Rev. Drug Discov., 17, 261, 10.1038/nrd.2017.243 Vallazza, 2015, Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond, Wiley Interdiscip. Rev. RNA, 6, 471, 10.1002/wrna.1288 Diken, 2011, Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation, Gene Ther., 18, 702, 10.1038/gt.2011.17 Sahin, 2017, Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer, Nature, 547, 222, 10.1038/nature23003 Kranz, 2016, Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy, Nature, 534, 396, 10.1038/nature18300 Holtkamp, 2006, Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells, Blood, 108, 4009, 10.1182/blood-2006-04-015024 Princiotta, 2003, Quantitating protein synthesis, degradation, and endogenous antigen processing, Immunity, 18, 343, 10.1016/S1074-7613(03)00051-7 Steinle, 2017, Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges, Stem Cells, 35, 68, 10.1002/stem.2402 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Brambrink, 2008, Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells, Cell Stem Cell, 2, 151, 10.1016/j.stem.2008.01.004 Ben-David, 2011, The tumorigenicity of human embryonic and induced pluripotent stem cells, Nat. Rev. Cancer, 11, 268, 10.1038/nrc3034 Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934 Davies, 1992, The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2, J. Virol., 66, 1943, 10.1128/jvi.66.4.1943-1950.1992 Romano, 1998, Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain, Mol. Cell. Biol., 18, 7304, 10.1128/MCB.18.12.7304 Symons, 1995, Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity, Cell, 81, 551, 10.1016/0092-8674(95)90076-4 Poleganov, 2015, Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion, Hum. Gene Ther., 26, 751, 10.1089/hum.2015.045 Wilkins, 2010, Recognition of viruses by cytoplasmic sensors, Curr. Opin. Immunol., 22, 41, 10.1016/j.coi.2009.12.003 Anokye-Danso, 2011, Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency, Cell Stem Cell, 8, 376, 10.1016/j.stem.2011.03.001 Chen, 2012, Synergetic cooperation of microRNAs with transcription factors in iPS cell generation, PLoS ONE, 7, e40849, 10.1371/journal.pone.0040849 Guhaniyogi, 2001, Regulation of mRNA stability in mammalian cells, Gene, 265, 11, 10.1016/S0378-1119(01)00350-X Schwanhäusser, 2011, Global quantification of mammalian gene expression control, Nature, 473, 337, 10.1038/nature10098 Tanguay, 1996, Translational efficiency is regulated by the length of the 3′ untranslated region, Mol. Cell. Biol., 16, 146, 10.1128/MCB.16.1.146 Peixeiro, 2011, Control of human beta-globin mRNA stability and its impact on beta-thalassemia phenotype, Haematologica, 96, 905, 10.3324/haematol.2010.039206 Waggoner, 2003, Regulation of alpha-globin mRNA stability, Exp. Biol. Med. (Maywood), 228, 387, 10.1177/153537020322800409 Russell, 1997, The role of mRNA stability in the control of globin gene expression, Prog. Nucleic Acid Res. Mol. Biol., 57, 249, 10.1016/S0079-6603(08)60283-4 Aviv, 1976, Biosynthesis and stability of globin mRNA in cultured erythroleukemic Friend cells, Cell, 8, 495, 10.1016/0092-8674(76)90217-8 Ross, 1985, Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes, Blood, 66, 1149, 10.1182/blood.V66.5.1149.1149 Ellington, 1990, In vitro selection of RNA molecules that bind specific ligands, Nature, 346, 818, 10.1038/346818a0 Tuerk, 1990, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science, 249, 505, 10.1126/science.2200121 Chrzanowska-Lightowlers, 2001, Fending off decay: a combinatorial approach in intact cells for identifying mRNA stability elements, RNA, 7, 435, 10.1017/S1355838201001339 Yuhashi, 2014, In vitro selection of the 3′-untranslated regions of the human liver mRNA that bind to the HCV nonstructural protein 5B, Virology, 450-451, 13, 10.1016/j.virol.2013.11.036 Yang, 2003, Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes, Genome Res., 13, 1863, 10.1101/gr.1272403 Li, 1998, Generation of destabilized green fluorescent protein as a transcription reporter, J. Biol. Chem., 273, 34970, 10.1074/jbc.273.52.34970 Diken, 2013, mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA, Cancer Immunol. Res., 1, 386, 10.1158/2326-6066.CIR-13-0046 Kreiter, 2011, FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines, Cancer Res., 71, 6132, 10.1158/0008-5472.CAN-11-0291 Van Nuffel, 2012, Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients, Mol. Ther., 20, 1063, 10.1038/mt.2012.11 Hashimi, 2009, MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation, Blood, 114, 404, 10.1182/blood-2008-09-179150 Landgraf, 2007, A mammalian microRNA expression atlas based on small RNA library sequencing, Cell, 129, 1401, 10.1016/j.cell.2007.04.040 Brümmer, 2014, MicroRNA binding sites in the coding region of mRNAs: extending the repertoire of post-transcriptional gene regulation, BioEssays, 36, 617, 10.1002/bies.201300104 Bradley, 1997, Recombinant DNA sequences generated by PCR amplification, Mol. Biol. Evol., 14, 592, 10.1093/oxfordjournals.molbev.a025797 Kuhn, 2011, Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics, RNA Biol., 8, 35, 10.4161/rna.8.1.13767 Thiel, 2011, Nucleotide bias observed with a short SELEX RNA aptamer library, Nucleic Acid Ther., 21, 253, 10.1089/nat.2011.0288 Javorovic, 2005, RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysis, Mol. Ther., 12, 734, 10.1016/j.ymthe.2005.03.034 Jackson, 2010, The mechanism of eukaryotic translation initiation and principles of its regulation, Nat. Rev. Mol. Cell Biol., 11, 113, 10.1038/nrm2838 Chinnery, 2013, Mitochondrial genetics, Br. Med. Bull., 106, 135, 10.1093/bmb/ldt017 Schon, 2012, Human mitochondrial DNA: roles of inherited and somatic mutations, Nat. Rev. Genet., 13, 878, 10.1038/nrg3275 Costa, 2013, GRG5/AES interacts with T-cell factor 4 (TCF4) and downregulates Wnt signaling in human cells and zebrafish embryos, PLoS ONE, 8, e67694, 10.1371/journal.pone.0067694 Okada, 2017, Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer, Cancer Sci., 108, 744, 10.1111/cas.13187 Sonoshita, 2011, Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling, Cancer Cell, 19, 125, 10.1016/j.ccr.2010.11.008 Warren, 2010, Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA, Cell Stem Cell, 7, 618, 10.1016/j.stem.2010.08.012 Yoshioka, 2017, Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNA, PLoS ONE, 12, e0182018, 10.1371/journal.pone.0182018 Yoshioka, 2013, Efficient generation of human iPSCs by a synthetic self-replicative RNA, Cell Stem Cell, 13, 246, 10.1016/j.stem.2013.06.001 Kreiter, 2007, Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA, Cancer Immunol. Immunother., 56, 1577, 10.1007/s00262-007-0302-7 Kowalska, 2008, Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS, RNA, 14, 1119, 10.1261/rna.990208 Wright, 2014, CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains, Nucleic Acids Res., 42, W119, 10.1093/nar/gku359 Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 Koste, 2014, T-cell receptor transfer into human T cells with ecotropic retroviral vectors, Gene Ther., 21, 533, 10.1038/gt.2014.25 Kuhn, 2010, Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo, Gene Ther., 17, 961, 10.1038/gt.2010.52 Slansky, 2000, Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex, Immunity, 13, 529, 10.1016/S1074-7613(00)00052-2